| Dec 24, 2025 | TargED Biopharmaceuticals | $25.4M Series A Extension | Rianne Ellenbroek | Andera Partners, INKEF Capital, Curie Capital, Fund+, Sunstone Life Science Ventures |
| Oct 1, 2025 | Step Pharma | $44.0M Series C | 🧪 Ward Capoen | HealthCap, Pontifax Venture Capital, RA Capital, Ysios Capital, Bpifrance, Inserm Transfert Initiative, Kurma Partners, Sunstone Life Science Ventures |
| Sep 1, 2025 | ARTHEx Biotech | $41.0M Series B | Laurent Higueret | Advent Life Sciences, Alta Life Sciences, Sanofi Ventures, Ysios Capital, Advent France Biotechnology, CDTI Innvierte, José Antonio Mesa, European Innovation Council, Invivo Capital, Sound Bioventures |
| Jul 1, 2025 | Actithera | $76.0M Series A | M Ventures (Merck), Therese Liechtenstein, Roger Franklin, Karl Nagler | Cambridge Innovation Capital, MP Healthcare Venture Management, Hakan Goker, Noga Yerushalmi, SV Health Investors, Arkin Bio Ventures, Debora Dumont, Innovestor, Investinor, Surveyor Capital |
| Jul 1, 2024 | SciRhom | $68.0M Series A | Andera Partners, Hadean Ventures, Kurma Partners, MIG Capital, Wellington Partners | Deerfield Management |
| Apr 1, 2023 | Complement Therapeutics | $79.0M Series A | Forbion, Michaël Vlemmix | Andera Partners, Max Klement, Cambridge Innovation Capital, EQT Life Sciences, Kurma Partners, Sanofi Ventures, Ysios Capital, BioGeneration Ventures, Roger Franklin, Rob Woodman, Seroba Life Sciences |
| Feb 1, 2022 | TargED Biopharmaceuticals | $44.0M Series A | Andera Partners, INKEF Capital, Jan Van den Bossche, Roger Franklin, Jacob Lange Moresco | Ysios Capital, Mariette van der Velden, FIRST, Utrecht Health Seed Fund |
| Jan 31, 2022 | Ribbon Biolabs | $20.1M Series A | Walter Stockinger | Helicase Venture, IST cube, Lansdowne Partners, tecnet equity |
| Dec 1, 2021 | Emergence Therapeutics | $98.0M Series A | Pontifax Venture Capital | Andera Partners, EQT Life Sciences, High-Tech Gründerfonds, Kurma Partners, Olivier Martinez, Gründerfonds Ruhr, Roger Franklin, High-Tech Grunderfonds, Marek Kozlowski, PhD MScEng, Roy Amariglio, Matthew Hammond |
| Aug 1, 2021 | Cardior Pharmaceuticals | $75.0M Series B | INKEF Capital | BioMedPartners, Bristol Myers Squibb, coparion, Fund+, High-Tech Grunderfonds, Karin Kleinhans, Sunstone Capital |
| Mar 1, 2021 | Step Pharma | $41.0M Series B | Walter Stockinger, Sunstone Life Science Ventures | HealthCap, Kurma Partners, Pontifax Venture Capital, RA Capital, Ysios Capital, Bpifrance |
| Sep 29, 2020 | Galecto | $64.0M Other Equity | Stephan Christgau, Guy Levy | Asymmetry Capital Management, Bristol Myers Squibb, Canica, Cormorant Asset Management, Hans Schambye, HBM Healthcare Investments, Janus Henderson Investors, Maverick Ventures, Novo Holdings, OrbiMed, Seventure Partners, Sphera, Sunstone Capital, Ysios Capital |
| Aug 1, 2020 | CardioMech | $19.0M Series A | — | Investinor, Ingrid Teigland Akay, Ann-Tove Kongsnes |
| Dec 1, 2019 | Pipeline Therapeutics | $32.0M Series B | Stefan Larson | Buff Gold Ventures, Versant Ventures, RBV Capital |
| Sep 1, 2019 | Themis Bioscience | $44.0M Series D | Farallon Capital Management, Walter Stockinger | Adjuvant Capital, IST cube, aws Gruenderfonds, Global Health Investment Fund, MSD, Omnes Capital, Ventech, Wellington Partners |
